Crystalline forms of a factor Xa inhibitor

Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07371864

ABSTRACT:
The instant invention provides crystalline forms of 3-(1-hydroxy-1-methyl-ethyl)-1-(4-methoxy-phenyl)-6-[4-(2-oxo-2H-pyridin-1-yl)-phenyl]-1,4,5,6-tetrahydro-pyrazolo[3,4-c]pyridin-7-one and its solvates thereof; processes for the production of such crystalline forms; pharmaceutical compositions comprising such crystalline forms; and methods of treating thromboembolic disorders with such crystalline forms or such pharmaceutical compositions.

REFERENCES:
patent: 6967208 (2005-11-01), Pinto et al.
patent: 2003/0191115 (2003-10-01), Pinto et al.
patent: 03/026652 (2003-03-01), None
patent: WO 2006/036927 (2006-04-01), None
U.S. Appl. No. 11/234,942, filed Sep. 26, 2005, Zhang et al.
U.S. Appl. No. 11/235,647, filed Sep. 26, 2005, Mudryk et al.
U.S. Appl. No. 11/235,731, filed Sep. 26, 2005, Zhang et al.
Elodi, S. et al., “Optimization of Conditions for the Catalytic Effect of The Factor IXa—Factor VII Complex: Probable role of the complex in the amplification of blood coagulation”, Thrombosis Research, vol. 15, pp. 617-629 (1979).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Crystalline forms of a factor Xa inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crystalline forms of a factor Xa inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystalline forms of a factor Xa inhibitor will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2758840

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.